M Poulsen

Summary

Country: Australia

Publications

  1. ncbi request reprint Merkel-cell carcinoma of the skin
    Michael Poulsen
    Southern Zone Radiation Oncology Service Mater Centre, Queensland, Australia
    Lancet Oncol 5:593-9. 2004
  2. doi request reprint Comparison of a Commonwealth-initiated regional radiation oncology facility in Toowoomba with a Queensland Health facility
    M Poulsen
    Radiation Oncology Queensland, Toowoomba, QLD
    J Med Imaging Radiat Oncol 54:368-74. 2010
  3. doi request reprint Factors associated with subjective well-being in cancer workers in Queensland
    Michael G Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
    J Med Imaging Radiat Oncol 56:347-53. 2012
  4. doi request reprint Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone
    Michael Geoffrey Poulsen
    Department of Radiation Oncology, Princess Alexandra Hospital, QLD, Australia
    Radiother Oncol 87:253-9. 2008
  5. ncbi request reprint Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
    Michael G Poulsen
    University of Queensland, Southern Zone Radiation Oncology, Raymond Tce, South Brisbane, QLD, Australia
    Int J Radiat Oncol Biol Phys 64:114-9. 2006
  6. doi request reprint Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin
    Michael Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia
    Int J Radiat Oncol Biol Phys 72:1070-4. 2008
  7. ncbi request reprint High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07
    Michael Poulsen
    Mater Queensland Radium Institute, Raymond Tee, South Brisbane, QLD 4101 Australia
    J Clin Oncol 21:4371-6. 2003
  8. ncbi request reprint Merkel cell carcinoma--current therapeutic options
    Michael Poulsen
    Mater Queensland Radium Institute, Raymond Terrace, South Brisbane, Queensland 4101, Australia
    Expert Opin Pharmacother 4:2187-92. 2003
  9. doi request reprint Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb--a review of 60 cases
    Michael Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia
    Int J Radiat Oncol Biol Phys 76:393-7. 2010
  10. doi request reprint Work engagement in cancer workers in Queensland: the flip side of burnout
    Michael G Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, Harlow, Essex, Australia
    J Med Imaging Radiat Oncol 55:425-32. 2011

Collaborators

Detail Information

Publications23

  1. ncbi request reprint Merkel-cell carcinoma of the skin
    Michael Poulsen
    Southern Zone Radiation Oncology Service Mater Centre, Queensland, Australia
    Lancet Oncol 5:593-9. 2004
    ..The treatment challenges for the clinician are often enormous because many of the patients are elderly and because lesions occur in difficult sites such as the head and neck region and the lower leg...
  2. doi request reprint Comparison of a Commonwealth-initiated regional radiation oncology facility in Toowoomba with a Queensland Health facility
    M Poulsen
    Radiation Oncology Queensland, Toowoomba, QLD
    J Med Imaging Radiat Oncol 54:368-74. 2010
    ..A paperless working environment is one factor that has allowed staffing levels to be reduced. Ongoing support from Governments are required if private facilities are to participate in important ongoing staff training...
  3. doi request reprint Factors associated with subjective well-being in cancer workers in Queensland
    Michael G Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
    J Med Imaging Radiat Oncol 56:347-53. 2012
    ..This study aims to describe factors associated with subjective well-being (SWB) in cancer workers in Queensland and compares results to normative data for the Australian population...
  4. doi request reprint Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone
    Michael Geoffrey Poulsen
    Department of Radiation Oncology, Princess Alexandra Hospital, QLD, Australia
    Radiother Oncol 87:253-9. 2008
    ..It was hypothesised that craniocaudal length of the treatment field to the upper neck and pharynx would correlate with grade 4 swallowing toxicity due to the increased volume of pharynx irradiated...
  5. ncbi request reprint Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
    Michael G Poulsen
    University of Queensland, Southern Zone Radiation Oncology, Raymond Tce, South Brisbane, QLD, Australia
    Int J Radiat Oncol Biol Phys 64:114-9. 2006
    ....
  6. doi request reprint Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin
    Michael Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia
    Int J Radiat Oncol Biol Phys 72:1070-4. 2008
    ..This regimen was compared with the Trans-Tasman Radiation Oncology Group 96:07 study, which used identical eligibility criteria but carboplatin and etoposide every 3 weeks during RT...
  7. ncbi request reprint High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07
    Michael Poulsen
    Mater Queensland Radium Institute, Raymond Tee, South Brisbane, QLD 4101 Australia
    J Clin Oncol 21:4371-6. 2003
    ..The effectiveness of synchronous carboplatin, etoposide, and radiation therapy was prospectively assessed in a group of patients with high-risk Merkel cell carcinoma (MCC) of the skin...
  8. ncbi request reprint Merkel cell carcinoma--current therapeutic options
    Michael Poulsen
    Mater Queensland Radium Institute, Raymond Terrace, South Brisbane, Queensland 4101, Australia
    Expert Opin Pharmacother 4:2187-92. 2003
    ..The presence of distant disease carries a grave outlook with responses to chemotherapy occurring frequently, albeit of short duration...
  9. doi request reprint Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb--a review of 60 cases
    Michael Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, University of Queensland, Brisbane, Australia
    Int J Radiat Oncol Biol Phys 76:393-7. 2010
    ..Factors affecting relapse-free survival (RFS) in patients with Merkel cell carcinoma (MCC) of the lower limb were reviewed...
  10. doi request reprint Work engagement in cancer workers in Queensland: the flip side of burnout
    Michael G Poulsen
    Division of Cancer Services, Princess Alexandra Hospital, Harlow, Essex, Australia
    J Med Imaging Radiat Oncol 55:425-32. 2011
    ..The study aimed to investigate factors associated with work engagement and burnout in cancer workers in Queensland...
  11. ncbi request reprint Locally advanced tonsillar squamous cell carcinoma: Treatment approach revisited
    Michael Poulsen
    Southern Zone Radiation Oncology, Mater Queensland Radium Institute, South Brisbane, Australia
    Laryngoscope 117:45-50. 2007
    ..The purpose of this study was to review the treatment policy for locally advanced stage III and IV squamous cell carcinoma (SCC) of the tonsil at the Princess Alexandra Hospital Head and Neck Unit, Brisbane, Australia...
  12. ncbi request reprint Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study
    M Poulsen
    Division of Oncology Incorporating Queensland Radium Institute, Royal Brisbane Hospital, Herston, Queensland, Australia
    Int J Radiat Oncol Biol Phys 51:156-63. 2001
    ..The acute and late toxicities of synchronous carboplatin, etoposide, and radiation therapy were prospectively assessed in a group of patients with high-risk Merkel cell carcinoma of the skin...
  13. doi request reprint Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide
    S V Porceddu
    Radiation Oncology Deparmtent, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    J Med Imaging Radiat Oncol 52:491-6. 2008
    ..001). These results provide a quantitative guide for the clinician as to the likelihood of regional control based on pretreatment nodal size following CRT in patients who achieve a CR at the primary site by 12 weeks post-treatment...
  14. ncbi request reprint Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Trans-Tasman Radiation Oncology Group
    C Hamilton
    Department of Radiation Oncology, Newcastle Mater Misericordiae Hospital, New South Wales, Australia
    Australas Radiol 43:227-32. 1999
    ..Ultimately, comprehensive clinical and technical QA site visits are planned...
  15. ncbi request reprint Is there a diminishing role for surgery for Merkel cell carcinoma of the skin? a review of current management
    M Poulsen
    Division of Oncology, Mater Queensland Radium Institute, Brisbane, Australia
    ANZ J Surg 72:142-6. 2002
    ..The presence of distant disease carries a grave outlook and responses to chemotherapy occur frequently, but are usually shortlived...
  16. ncbi request reprint Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes
    Jennifer L Andruchow
    Sydney Head and Neck Cancer Institute, Sydney Cancer Centre, Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia
    Cancer 106:1078-83. 2006
    ..Previous studies have highlighted limitations with the current TNM staging system for metastatic skin carcinoma. The aim of this study was to test a new staging system that may provide better discrimination between patient groups...
  17. ncbi request reprint Preservation of form and function in the management of head and neck skin cancer
    Michael Poulsen
    Mater Queensland Radium Institute, Raymond Tce, South Brisbane, Brisbane, Queensland, Australia 4101
    World J Surg 27:868-74. 2003
    ..A multidisciplinary approach is required in the more difficult cases. Adequate histologic analysis of margins and assessment of adverse prognostic features are crucial in the selection of therapy...
  18. ncbi request reprint Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
    Danny Rischin
    Division of Haematology and Medical Oncology, University of Melbourne, Peter MacCallum Cancer Centre, Locked Bag No 1, A Beckett St, Melbourne 8006, Australia
    J Clin Oncol 23:79-87. 2005
    ..To select one of two chemoradiotherapy regimens for locally advanced squamous cell carcinoma (SCC) of the head and neck as the experimental arm for the next Trans-Tasman Radiation Oncology Group phase III trial...
  19. ncbi request reprint Merkel cell carcinoma of skin: diagnosis and management strategies
    Michael Poulsen
    Southern Zone Radiation Oncology Services, Mater Centre, Brisbane, Queensland, Australia
    Drugs Aging 22:219-29. 2005
    ..An aggressive treatment approach is warranted at the first attempt to treat MCC as treatment for recurrent disease is less likely to be successful...
  20. ncbi request reprint Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial"
    Sandro V Porceddu
    Southern Area Radiation Oncology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Queensland 4102, Australia
    Radiother Oncol 85:456-62. 2007
    ..Secondary objectives included radiation toxicity, symptom control, quality of life (QoL) and progression-free and overall survival...
  21. ncbi request reprint Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation
    David Christie
    East Coast Cancer Centre, Tugun, Queensland, Australia
    Radiother Oncol 77:117-25. 2005
    ..To identify contributing factors to delayed rectal and urinary symptoms in a randomised trial comparing different durations of maximal androgen deprivation (MAD), given prior to radiotherapy, for locally advanced prostate cancer...
  22. ncbi request reprint Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer
    David S Lamb
    Wellington Cancer Centre, Wellington, New Zealand
    Radiother Oncol 68:255-67. 2003
    ..To determine the acceptability of short term neo-adjuvant maximal androgen deprivation (MAD) to patients treated with external beam radiation for locally advanced prostate cancer...
  23. ncbi request reprint Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database
    David L Ball
    Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    J Thorac Oncol 1:667-72. 2006
    ..As part of the preliminary analyses for the Trans-Tasman Radiation Oncology Group 99-05 study, the authors performed this analysis to determine to what extent stage reflects tumor volume...